Last edition
News about "develop next-generation respiratory inhalers"
Honeywell collaborates with AstraZeneca to develop next-generation respiratory inhalers
AstraZeneca is working to incorporate Honeywell?s Solstice Air (HFO-1234ze cGMP) technology as a medical propellant, reducing the greenhouse gas emissions of the pMDIs by up to 99.9 per cent when compared to current inhaler propellants. Solstice Air is the only non-flammable, near-zero GWP propellant available and in clinical development today for pMDIs
Develop Next-generation Respiratory Inhalers | 23/02/2022 | By Darshana | 611
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy